TNFR1 loss in the antigen-retaining tumor model alters inflammatory responsiveness and CAR-T-cell functional fitness
Resistance to CAR-T-cell therapy remains a major challenge in solid tumors, where target antigen expression may be retained despite cytotoxic T-cell attack. Resistance of tumor cells to cytokine killing mediated by T-cell-secreted tumor necrosis factor (TNF) and interferon-γ (IFN-γ) may contribute to this phenotype. We investigated this possibility using a CD19 antigen-retaining tumor-cell model with differential TNFR1 status, co-cultured in vitro with CAR-T cells. CRISPR/Cas9-mediated ablation of TNFR1 in tumor cells attenuated cytokine-induced apoptotic responses. At the molecular level, TNFR1-knockout cells exhibited reduced NF-κB activation, attenuated ICAM1 induction, and diminished caspase-3/7 activity compared with WT control cells. To assess the consequences of CAR-T-cell exposure to these resistant tumor cells, CAR-T cells were analysed following both short-term and serial long-term exposure to TNFR1-knockout target cells. Although short-term assays showed no reduction in CAR-T-cell/tumor-cell conjugate formation, serial exposure to surviving TNFR1-deficient tumor cells was associated with reduced CAR-T-cell cytotoxicity upon rechallenge. These CAR-T cells also displayed lower cytokine output and altered transcriptional states. Targeted single-cell profiling identified a CXCL13-associated cycling CAR-T-cell state during tumor-cell co-culture. A transcriptional signature derived from this CAR-T state was also detectable, in an exploratory analysis, in an independently clustered repeated CD3/CD28-stimulation dataset and in publicly available immune checkpoint blockade cohorts. Taken together, our findings support the hypothesis that prolonged exposure to antigen-positive tumor cells that survive inflammatory cytokine-mediated killing may reduce subsequent CAR-T-cell functional fitness and cytotoxic potential.
Authors
- Bayansulu Ilyassova (ORCID: https://orcid.org/0009-0000-7129-3718)
- Ksenia Levchuk (ORCID: https://orcid.org/0000-0002-2883-2496)
- Nickolai A. Barlev (ORCID: https://orcid.org/0000-0001-7111-2446)
- Alexey V. Pindyurin (ORCID: https://orcid.org/0000-0001-6959-0641)
- Shynggys Tursymbek
- Sergey Silonov (ORCID: https://orcid.org/0000-0001-8714-6659)
- Evgeniya Omelina
- Alexey Petukhov
Institutions
- Russian Academy of Sciences (RU)
- Institute of Cytology (RU)
- Institute of Molecular and Cell Biology (RU)
- Astana Medical University (KZ)
- National Research Center for Maternal and Child Health (KZ)
- Nazarbayev University (KZ)
Publication Details
- Journal
- Cell Death and Disease
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1038/s41419-026-09406-5
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00